title: Autonomic fiber sprouting in the skin in chronic inflammation.
abstract: Pain is a major symptom associated with chronic inflammation. In previous work from our laboratory, we have shown that in animal models of neuropathic pain there is a sprouting of sympathetic fibers into the upper dermis, a territory normally devoid of them. However, it is not known whether such sympathetic sprouting, which is likely trophic factor mediated, also occurs in chronic inflammation and arthritis. In the present study, we used a rat model of chronic inflammation in which a small single dose of complete Freund's adjuvant (CFA) was injected subcutaneously, unilaterally, into the plantar surface of the hindpaw. This led to a localized long-term skin inflammation and arthritis in all joints of the hindpaw. Animals were perfused with histological fixatives at 1, 2, 3 or 4 weeks after the injection. Experimental animals treated with CFA were compared to saline-injected animals. We then investigated the changes in the pattern of peripheral innervation of the peptidergic nociceptors and sympathetic fibers in rat glabrous hindpaw skin. Antibodies directed towards calcitonin gene-related peptide (CGRP) and dopamine beta-hydroxylase (DBH) were used for the staining of peptidergic and sympathetic fibers, respectively. Immunofluorescence was then used to analyze the different nerve fiber populations of the upper dermis. At 4 weeks following CFA treatment, DBH-immunoreactive (IR) fibers were found to sprout into the upper dermis, in a pattern similar to the one we had observed in animals with a chronic constriction injury of the sciatic nerve in a previous publication. There was also a significant increase in the density of CGRP-IR fibers in the upper dermis in CFA treated animals at 2, 3 and 4 weeks post-injection. The increased peptidergic fiber innervation and the ectopic autonomic fibers found in the upper dermis may have a role in the pain-related behavior displayed by these animals.
authors.affiliation: Department of Pharmacology & Therapeutics, McGill University, Montreal, Quebec, Canada. lina.almarestani@mcgill.ca
authors.forename: Lina
authors.initials: L
authors.lastname: Almarestani
authors.forename: Geraldine
authors.initials: G
authors.lastname: Longo
authors.forename: Alfredo
authors.initials: A
authors.lastname: Ribeiro-da-Silva
mesh_terms: D000818:Animals; D001341:Autonomic Nervous System / Q000187:drug effects / Q000473:pathology*; D002908:Chronic Disease; D020405:Dermis / Q000187:drug effects / Q000294:innervation / Q000473:pathology; D005620:Freund's Adjuvant / Q000008:administration & dosage / Q000494:pharmacology; D007249:Inflammation / Q000473:pathology*; D018613:Microscopy, Confocal; D009412:Nerve Fibers / Q000187:drug effects / Q000473:pathology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012867:Skin / Q000187:drug effects / Q000294:innervation* / Q000473:pathology*; D012965:Sodium Chloride / Q000008:administration & dosage / Q000494:pharmacology
chemical_list: D012965:Sodium Chloride; D005620:Freund's Adjuvant